Eterna Therapeutics Inc (ERNA) concluded trading on Wednesday at a closing price of $0.64, with 12.56 million shares of worth about $8.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -68.21% during that period and on January 22, 2025 the price saw a gain of about 35.44%. Currently the company’s common shares owned by public are about 51.37M shares, out of which, 48.88M shares are available for trading.
Stock saw a price change of 38.67% in past 5 days and over the past one month there was a price change of 135.22%. Year-to-date (YTD), ERNA shares are showing a performance of 116.02% which decreased to -54.31% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $2.62 during that period. The average intraday trading volume for Eterna Therapeutics Inc shares is 10.79 million. The stock is currently trading 80.65% above its 20-day simple moving average (SMA20), while that difference is up 35.40% for SMA50 and it goes to -54.31% lower than SMA200.
Eterna Therapeutics Inc (NASDAQ: ERNA) currently have 51.37M outstanding shares and institutions hold larger chunk of about 1.38% of that.
The stock has a current market capitalization of $32.63M and its 3Y-monthly beta is at 4.37. It has posted earnings per share of -$8.31 in the same period. It has Quick Ratio of 0.48. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ERNA, volatility over the week remained 35.29% while standing at 26.50% over the month.
Analysts are in expectations that Eterna Therapeutics Inc (ERNA) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
